Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi International Journal of Cardiovascular ResearchISSN: 2324-8602
Marlene Shehata Author
Subjects of specialization
Affiliation
Smoking Cessation
Marlene Shehata Pharmaceuticals, Southwestern Ontario, Canada
Biography
Marlene Shehata Pharmaceuticals, Southwestern Ontario, Canada , As per Health Canada, - 17% of Canadians (i.e. 4.9 million) are active smokers of 15 years and older. According to the Canadian Cancer Society (Smokers Help Line) , 47,000 Canadians die from smoking each year, and lung cancer (although preventable) is the leading cause of cancer death for both men and women in Canada.
Publications
Editorial Open Access
Aliskiren: Is Combination Therapy with Angiotensin Converting Enzyme Inhibitors(ACE-I) or Angiotensin Receptor Blockers (ARBS) still a Possibility?
Author(s): Marlene Shehata, Fady Youssef and Alan Pater
Aliskiren: Is Combination Therapy with Angiotensin Converting Enzyme Inhibitors(ACE-I) or Angiotensin Receptor Blockers (ARBS) still a Possibility?
Aliskiren is a blood pressure-lowering agent, which is the first representative of a class of orally active renin inhibitors that directly blocks the Renin-Angiotensin-Aldosterone-System (RAAS) at its rate limiting step. Aliskiren reduces blood pressure by direct renin inhibition and causes a net reduction in plasma renin activity, angiotensin II and aldosterone levels. Aliskiren is marketed in Canada by Novartis under th... view more»
Google Scholars / Researchers Sites
